Ulrike Seifert Selected Research

Ulrike Seifert Research Topics

Disease

11	Neoplasms (Cancer) 01/2020 - 08/2006
8	Melanoma (Melanoma, Malignant) 01/2020 - 08/2006
4	Infections 01/2022 - 11/2006
2	Pneumococcal Infections 01/2022 - 01/2017
2	Inflammation (Inflammations) 01/2021 - 08/2010
2	Toxoplasmosis 01/2021 - 03/2016
2	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 03/2016
2	Virus Diseases (Viral Diseases) 12/2007 - 11/2006
1	Autoimmune Diseases (Autoimmune Disease) 03/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Coinfection 01/2022
1	Neoplasm Metastasis (Metastasis) 01/2020
1	Uterine Cervical Dysplasia 02/2019
1	Leukemia 01/2019
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2019
1	Myeloid Leukemia (Leukemia, Myelocytic) 01/2019
1	Colitis 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 09/2017
1	Multiple Myeloma 09/2017
1	Necrotizing Pneumonia 01/2017
1	Amyloid Plaque 03/2016
1	Cognitive Dysfunction 03/2016
1	Myocarditis (Carditis) 10/2014
1	Heart Failure 10/2014
1	Cardiomyopathies (Cardiomyopathy) 10/2014
1	Multiple Sclerosis 02/2010
1	Hepatocellular Carcinoma (Hepatoma) 11/2006
1	Insulin Resistance 04/2005
1	Chronic Hepatitis C 07/2004

Drug/Important Bio-Agent (IBA)

9	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2020 - 08/2006
8	EpitopesIBA 01/2020 - 04/2007
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2004
7	AntigensIBA 01/2020 - 04/2007
6	Peptides (Polypeptides)IBA 01/2021 - 04/2007
4	Messenger RNA (mRNA)IBA 01/2020 - 11/2006
3	InterferonsIBA 01/2021 - 10/2014
3	AminopeptidasesIBA 01/2020 - 12/2007
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 01/2016
3	MART-1 AntigenIBA 01/2018 - 12/2015
2	Differentiation AntigensIBA 01/2020 - 12/2015
2	Proteasome InhibitorsIBA 09/2017 - 08/2006
2	UbiquitinIBA 01/2016 - 10/2014
2	Viral RNAIBA 12/2007 - 11/2006
2	Tyrosine (L-Tyrosine)FDA Link 04/2005 - 07/2004
1	Ligases (Synthetase)IBA 03/2022
1	ProteomeIBA 01/2022
1	VaccinesIBA 01/2022
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2022
1	COVID-19 VaccinesIBA 01/2022
1	I-antigenIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Glutamate Receptors (Glutamate Receptor)IBA 01/2019
1	N-Methylaspartate (NMDA)IBA 01/2019
1	Caspase 9IBA 01/2019
1	Potassium Channels (Potassium Channel)IBA 01/2019
1	Caspase 3 (Caspase-3)IBA 01/2019
1	Memantine (Namenda)FDA Link 01/2019
1	Cytochromes c (Cytochrome c)IBA 01/2019
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2019
1	Pharmaceutical PreparationsIBA 01/2019
1	AcidsIBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 01/2018
1	Histocompatibility Antigens Class IIBA 01/2018
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2018
1	SodiumIBA 01/2018
1	Sulfates (Sulfates, Inorganic)IBA 01/2018
1	Bortezomib (Velcade)FDA Link 09/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	CytokinesIBA 01/2017
1	Amyloid (Amyloid Fibrils)IBA 03/2016
1	Peptide Hydrolases (Proteases)FDA Link 10/2014
1	CollagenIBA 10/2014
1	Eukaryotic Initiation Factor-4G (Eukaryotic Initiation Factor 4G)IBA 10/2014
1	Peptide Initiation Factors (Initiation Factor)IBA 10/2014
1	UbiquitinsIBA 10/2014
1	nardilysinIBA 01/2011
1	ElementsIBA 02/2010
1	HLA-A*02:01 antigenIBA 04/2007
1	RNA (Ribonucleic Acid)IBA 11/2006
1	Poly I-CIBA 11/2006
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 11/2006
1	Cisplatin (Platino)FDA LinkGeneric 08/2006
1	CalpainIBA 08/2006
1	Biological ProductsIBA 08/2006
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 04/2005
1	Serine (L-Serine)FDA Link 04/2005
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2005
1	Insulin ReceptorIBA 04/2005
1	Phenylalanine (L-Phenylalanine)FDA Link 07/2004

Therapy/Procedure

8	Therapeutics 01/2020 - 11/2006
4	Immunotherapy 01/2020 - 12/2015
2	Aftercare (After-Treatment) 02/2019 - 01/2019
1	Drug Therapy (Chemotherapy) 08/2006